AMRI Accused of Filing Misleading Proxy Statement, Injuring Stockholders
November 28, 2017 Albany Molecular Research, Inc. (AMRI) and its board of directors are facing a lawsuit along with The Carlyle Group, L.P., GTCR LLC, and several of their affiliates over the proposed acquisition of AMRI by Carlyle and GTCR.